Showing results (51-60 of 57) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
BMC Gastroenterology|June 13, 2021
Sofosbuvir/velpatasvir is an effective treatment for patients with hepatitis C and advanced fibrosis or cirrhosis in a real-world setting in TaiwanYu-Ting Huang, Yung-Yu Hsieh, Wei-Ming Chen, et al.Journal of Gastroenterology and Hepatology|May 12, 2021
Pangenotypic direct-acting antiviral agents for mixed genotype hepatitis C infection: A real-world effectiveness analysisYuan-Jie Ding, Chung-Kuang Lu, Wei-Ming Chen, et al.Plos One|August 18, 2022
Comparison of 8- versus 12-weeks of glecaprevir/pibrentasvir for Taiwanese patients with hepatitis C and compensated cirrhosis in a real-world settingYung-Hsin Lu, Chung-Kuang Lu, Chun-Hsien Chen, et al.International Journal of Molecular Sciences|September 7, 2016
Aberrant JAK/STAT Signaling Suppresses TFF1 and TFF2 through Epigenetic Silencing of GATA6 in Gastric CancerCheng-Shyong Wu, Kuo-Liang Wei, Jian-Liang Chou, et al.Harmful Algae|July 31, 2017
Taxonomic assignment of the benthic toxigenic dinoflagellate Gambierdiscus sp. type 6 as Gambierdiscus balechii (Dinophyceae), including its distribution and ciguatoxicityXinfeng Dai, Yim Ling Mak, Chung-Kuang Lu, et al.Redox Biology|August 28, 2025
Activation of CISD2 as a protective strategy against doxorubicin-induced cardiotoxicityYi-Ju Chou, Chi-Hsiao Yeh, Chian-Feng Chen, et al.Viruses|January 21, 2023
Direct-Acting Antivirals Reduce the De Novo Development of Esophageal Varices in Patients with Hepatitis C Virus Related Liver CirrhosisYung-Yu Hsieh, Wei-Ming Chen, Kao-Chi Chang, et al.Pageof 6